These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 12621347

  • 1. Gentamicin perfusion vestibular response and hearing loss.
    Light JP, Silverstein H, Jackson LE.
    Otol Neurotol; 2003 Mar; 24(2):294-8. PubMed ID: 12621347
    [Abstract] [Full Text] [Related]

  • 2. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 3. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 4. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 5. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 6. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 7. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome.
    Harner SG, Driscoll CL, Facer GW, Beatty CW, McDonald TJ.
    Otol Neurotol; 2001 Mar; 22(2):210-4. PubMed ID: 11300271
    [Abstract] [Full Text] [Related]

  • 9. [Vestibular neurotomy versus chemical labyrinthectomy for disabling Menière disease].
    Morel N, Dumas G, Nguyen DQ, Mohr E, Hitter A, Schmerber S.
    Ann Otolaryngol Chir Cervicofac; 2005 Dec; 122(6):271-80. PubMed ID: 16505777
    [Abstract] [Full Text] [Related]

  • 10. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N, Boleas MS, Martin E.
    Audiol Neurootol; 2005 Dec; 10(2):69-78. PubMed ID: 15650298
    [Abstract] [Full Text] [Related]

  • 11. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

  • 12. Cochlear implantation in patients with bilateral Ménière's syndrome.
    Lustig LR, Yeagle J, Niparko JK, Minor LB.
    Otol Neurotol; 2003 May; 24(3):397-403. PubMed ID: 12806291
    [Abstract] [Full Text] [Related]

  • 13. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of gentamicin inner ear perfusion in Ménière's disease.
    Suryanarayanan R, Cook JA.
    J Laryngol Otol; 2004 Jul; 118(7):489-95. PubMed ID: 15318953
    [Abstract] [Full Text] [Related]

  • 15. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G, Chung DW, van der Hoeven R, Verweij S, Becker M.
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [Abstract] [Full Text] [Related]

  • 16. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM, Hehar SS, Bance ML, Rutka JA.
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 18. Hearing and Vestibular Function After Preoperative Intratympanic Gentamicin Therapy for Vestibular Schwanomma as Part of Vestibular Prehab.
    Tjernström F, Fransson PA, Kahlon B, Karlberg M, Lindberg S, Siesjö P, Magnusson M.
    Ear Hear; 2016 Mar; 37(6):744-750. PubMed ID: 27438868
    [Abstract] [Full Text] [Related]

  • 19. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
    Wang XY.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun 20; 30(12):942-944. PubMed ID: 29771059
    [Abstract] [Full Text] [Related]

  • 20. Effect of intratympanically administered gentamicin on hearing and tinnitus in Menière's disease.
    Kaasinen S, Pyykkö I, Ishizaki H, Aalto H.
    Acta Otolaryngol Suppl; 1995 Jun 20; 520 Pt 1():184-5. PubMed ID: 8749114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.